Deep Learning and Neurology: A Systematic Review
来源期刊:Neurology and TherapyDOI:10.1007/s40120-019-00153-8
Fingolimod Rebound: A Review of the Clinical Experience and Management Considerations
来源期刊:Neurology and TherapyDOI:10.1007/s40120-019-00160-9
A Review on MS-Based Blood Biomarkers for Alzheimer’s Disease
来源期刊:Neurology and TherapyDOI:10.1007/s40120-019-00165-4
Salivary Biomarkers for Alzheimer’s Disease and Related Disorders
来源期刊:Neurology and TherapyDOI:10.1007/s40120-019-00168-1
Diagnosing and Treating Depression in Patients with Alzheimer’s Disease
来源期刊:Neurology and TherapyDOI:10.1007/s40120-019-00148-5
An Overview of High-Efficacy Drugs for Multiple Sclerosis: Gulf Region Expert Opinion
来源期刊:Neurology and TherapyDOI:10.1007/s40120-019-0129-0
Neurogenic Orthostatic Hypotension in Parkinson Disease: A Primer
来源期刊:Neurology and TherapyDOI:10.1007/s40120-019-00152-9
Reflections on the Utility of the Retina as a Biomarker for Alzheimer’s Disease: A Literature Review
来源期刊:Neurology and TherapyDOI:10.1007/s40120-019-00173-4
Real-World Characterization of Dimethyl Fumarate-Related Gastrointestinal Events in Multiple Sclerosis: Management Strategies to Improve Persistence on Treatment and Patient Outcomes
来源期刊:Neurology and TherapyDOI:10.1007/s40120-019-0127-2
Fingolimod Immune Effects Beyond Its Sequestration Ability
来源期刊:Neurology and TherapyDOI:10.1007/s40120-019-00162-7
Treatment Effectiveness for Resolution of Multiple Sclerosis Relapse in a US Health Plan Population
来源期刊:Neurology and TherapyDOI:10.1007/s40120-019-00156-5
Neurophysiological Markers of Alzheimer’s Disease: Quantitative EEG Approach
来源期刊:Neurology and TherapyDOI:10.1007/s40120-019-00169-0
Critical Steps to be Taken into Consideration Before Quantification of β-Amyloid and Tau Isoforms in Blood can be Implemented in a Clinical Environment
来源期刊:Neurology and TherapyDOI:10.1007/s40120-019-00166-3
Burden of Disease and Current Management of Dementia with Lewy Bodies: A Literature Review
来源期刊:Neurology and TherapyDOI:10.1007/s40120-019-00154-7
Polypharmacy in an Elderly Population: Enhancing Medication Management Through the Use of Clinical Decision Support Software Platforms
来源期刊:Neurology and TherapyDOI:10.1007/s40120-019-0131-6
Practical Guidance on the Use of Lurasidone for the Treatment of Adults with Schizophrenia
来源期刊:Neurology and TherapyDOI:10.1007/s40120-019-0138-z
An Update on Blood-Based Markers of Alzheimer’s Disease Using the SiMoA Platform
来源期刊:Neurology and TherapyDOI:10.1007/s40120-019-00164-5
Advance in Plasma AD Core Biomarker Development: Current Findings from Immunomagnetic Reduction-Based SQUID Technology
来源期刊:Neurology and TherapyDOI:10.1007/s40120-019-00167-2
Therapy of Sialorrhea with Botulinum Neurotoxin
来源期刊:Neurology and TherapyDOI:10.1007/s40120-019-00155-6
Two Sides to Every Story: Perspectives from Four Patients and a Healthcare Professional on Multiple Sclerosis Disease Progression
来源期刊:Neurology and TherapyDOI:10.1007/s40120-019-0141-4
Late Onset of Neuromyelitis Optica Spectrum Disorders
来源期刊:Neurology and TherapyDOI:10.1007/s40120-019-0143-2
Cognitive Fatigability Interventions in Neurological Conditions: A Systematic Review
来源期刊:Neurology and TherapyDOI:10.1007/s40120-019-00158-3
Effect of Anodal tDCS on Articulatory Accuracy, Word Production, and Syllable Repetition in Subjects with Aphasia: A Crossover, Double-Blinded, Sham-Controlled Trial
来源期刊:Neurology and TherapyDOI:10.1007/s40120-019-00149-4
Targeting Higher Levels of Tau Protein in Ukrainian Patients with Wilson’s Disease
来源期刊:Neurology and TherapyDOI:10.1007/s40120-019-0134-3
Bioavailability and Pharmacokinetics of Once-Daily Amantadine Extended-Release Tablets in Healthy Volunteers: Results from Three Randomized, Crossover, Open-Label, Phase 1 Studies
来源期刊:Neurology and TherapyDOI:10.1007/s40120-019-0144-1
A Novel Dual-Frequency Deep Brain Stimulation Paradigm for Parkinson’s Disease
来源期刊:Neurology and TherapyDOI:10.1007/s40120-019-0140-5
Real-World Treatment of Patients with Multiple Sclerosis per MS Subtype and Associated Healthcare Resource Use: An Analysis Based on 13,333 Patients in Germany
来源期刊:Neurology and TherapyDOI:10.1007/s40120-019-00172-5
The Treatment of Hypersalivation in Rett Syndrome with Botulinum Toxin: Efficacy and Clinical Implications
来源期刊:Neurology and TherapyDOI:10.1007/s40120-018-0125-9
Cerebrolysin as a New Treatment Option for Post-Stroke Spasticity: Patient and Physician Perspectives
来源期刊:Neurology and TherapyDOI:10.1007/s40120-019-0128-1
Tardive Reactivation of Progressive Multiple Sclerosis During Treatment with Biotin
来源期刊:Neurology and TherapyDOI:10.1007/s40120-019-00175-2
Biosimilar Drugs for Multiple Sclerosis: An Unmet International Need or a Regulatory Risk?
来源期刊:Neurology and TherapyDOI:10.1007/s40120-019-0145-0
PatientConcept App: Key Characteristics, Implementation, and its Potential Benefit
来源期刊:Neurology and TherapyDOI:10.1007/s40120-019-0133-4
Practical Issues Concerning the Approval and Use of Biosimilar Drugs for the Treatment of Multiple Sclerosis in Latin America
来源期刊:Neurology and TherapyDOI:10.1007/s40120-019-0139-y
Effectiveness and Safety/Tolerability of Eslicarbazepine Acetate in Epilepsy Patients Aged\u2009≥\u200960 Versus\u2009<\u200960 Years: A Subanalysis from the Euro-Esli Study
来源期刊:Neurology and TherapyDOI:10.1007/s40120-019-0137-0
Exercise in Multiple Sclerosis: Knowing is Not Enough—The Crucial Role of Intention Formation and Intention Realization
来源期刊:Neurology and TherapyDOI:10.1007/s40120-019-0136-1
Intravenous Milrinone Salvage Therapy in Acute Internal Carotid Artery Occlusion: Case Report
来源期刊:Neurology and TherapyDOI:10.1007/s40120-018-0124-x
Efficacy and Safety of Alemtuzumab in Patients of African Descent with Relapsing-Remitting Multiple Sclerosis: 8-Year Follow-up of CARE-MS I and II (TOPAZ Study)
来源期刊:Neurology and TherapyDOI:10.1007/s40120-019-00159-2
Peripheral Biomarkers for Alzheimer’s Disease: Update and Progress
来源期刊:Neurology and TherapyDOI:10.1007/s40120-019-00171-6
Long-Term Effect of Immediate Versus Delayed Fingolimod Treatment in Young Adult Patients with Relapsing–Remitting Multiple Sclerosis: Pooled Analysis from the FREEDOMS/FREEDOMS II Trials
来源期刊:Neurology and TherapyDOI:10.1007/s40120-019-0146-z
Neurology and Therapy: Looking Back on 2018 and Forward to 2019
来源期刊:Neurology and TherapyDOI:10.1007/s40120-019-0126-3
Abstracts from the 5th International Porto Congress of Multiple Sclerosis
来源期刊:Neurology and TherapyDOI:10.1007/s40120-019-0135-2
A Retrospective Analysis of Real-World Discontinuation Rates with Delayed-Release Dimethyl Fumarate in Patients with Relapsing–Remitting Multiple Sclerosis
来源期刊:Neurology and TherapyDOI:10.1007/s40120-019-00174-3
Knowledge Is Power, but Is Ignorance Bliss? Optimising Conversations About Disease Progression in Multiple Sclerosis
来源期刊:Neurology and TherapyDOI:10.1007/s40120-019-00170-7
Can Generic Intravenous Levetiracetam Be Used for Acute Repetitive Convulsive Seizure or Status Epilepticus? A Randomized Controlled Trial
来源期刊:Neurology and TherapyDOI:10.1007/s40120-019-00150-x
Adapting the Goal Attainment Approach for Major Depressive Disorder
来源期刊:Neurology and TherapyDOI:10.1007/s40120-019-00151-w
Correction to: Abstracts from the 5th International Porto Congress of Multiple Sclerosis
来源期刊:Neurology and TherapyDOI:10.1007/s40120-019-00161-8
Risperdal® CONSTA® Needle Detachment. Incidence Rates Before and After Kit Redesign: A Retrospective Study using Electronic Health Records and Natural Language Processing in the Department of Veterans Affairs
来源期刊:Neurology and TherapyDOI:10.1007/s40120-019-0130-7
Efficacy and Safety of Octagam® in Patients With Chronic Inflammatory Demyelinating Polyneuropathy
来源期刊:Neurology and TherapyDOI:10.1007/s40120-019-0132-5
Acknowledgement to Authors, Referees and Readers 2019
来源期刊:Neurology and TherapyDOI:10.1007/s40120-019-00163-6
Case Report of a Novel Technique for Repair of the Vertebral Artery During Cranial Surgery
来源期刊:Neurology and TherapyDOI:10.1007/s40120-019-0142-3